All In Biotech

Free tool

FAERS Monitor: Jylamvo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212479 or its brand name (Jylamvo, Methotrexate). Reports on generic versions are filed under their own applications.

Reports

415,539

Serious

315,071

76% of reports

Hospitalization

119,682

Death reported

34,392

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective75,829
  • rheumatoid arthritis38,595
  • arthralgia36,779
  • pain35,908
  • off label use35,260
  • fatigue29,599
  • nausea24,357
  • joint swelling22,621
  • headache21,284
  • rash20,346
  • condition aggravated20,228
  • drug intolerance20,017
  • diarrhoea18,641
  • pain in extremity18,097
  • pyrexia17,467

Reports by year received

View as table
YearReports
20045,129
20055,083
20064,969
20077,782
20088,995
20099,160
20109,678
201110,610
201214,953
201316,975
201416,960
201520,301
201621,746
201722,399
201831,886
201932,098
202039,615
202126,415
202229,157
202326,797
202423,073
202520,032
202611,717

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,638,620 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal38,59525.525.2604,267
drug intoleranceSignal20,01713.012.8176,074
joint swellingSignal22,62111.411.3176,172
arthralgiaSignal36,7794.84.8103,368
condition aggravatedSignal20,2283.53.534,849
pain in extremitySignal18,0973.23.226,781
painSignal35,9083.13.048,929
drug ineffectiveSignal75,8293.03.0103,624
pyrexiaSignal17,4672.62.617,146
rashSignal20,3462.42.416,654
off label useSignal35,2602.12.119,847
fatigue29,5992.01.913,920
headache21,2841.71.76,719
nausea24,3571.61.65,155
diarrhoea18,6411.51.52,861

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.